JPS636462A - Method for measuring specific component by using peroxidase enzyme reaction - Google Patents
Method for measuring specific component by using peroxidase enzyme reactionInfo
- Publication number
- JPS636462A JPS636462A JP15072386A JP15072386A JPS636462A JP S636462 A JPS636462 A JP S636462A JP 15072386 A JP15072386 A JP 15072386A JP 15072386 A JP15072386 A JP 15072386A JP S636462 A JPS636462 A JP S636462A
- Authority
- JP
- Japan
- Prior art keywords
- group
- specific component
- peroxidase
- label
- primary amine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108040007629 peroxidase activity proteins Proteins 0.000 title claims abstract description 15
- 238000006911 enzymatic reaction Methods 0.000 title claims abstract description 11
- 102000003992 Peroxidases Human genes 0.000 title claims abstract 6
- 238000000034 method Methods 0.000 title claims description 23
- 239000000758 substrate Substances 0.000 claims abstract description 22
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000002131 composite material Substances 0.000 claims abstract description 7
- -1 aromatic primary amine compound Chemical class 0.000 claims description 36
- 239000000975 dye Substances 0.000 abstract description 9
- 238000005259 measurement Methods 0.000 abstract description 5
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 238000002372 labelling Methods 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 3
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000001045 blue dye Substances 0.000 abstract 1
- 238000001962 electrophoresis Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 22
- 239000000243 solution Substances 0.000 description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 230000009870 specific binding Effects 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 10
- 102000013415 peroxidase activity proteins Human genes 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 8
- 125000003118 aryl group Chemical group 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 238000004040 coloring Methods 0.000 description 7
- 125000000623 heterocyclic group Chemical group 0.000 description 7
- 239000012085 test solution Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 239000000020 Nitrocellulose Substances 0.000 description 6
- 125000004429 atom Chemical group 0.000 description 6
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 229920001220 nitrocellulos Polymers 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 6
- 241000283707 Capra Species 0.000 description 5
- 150000001334 alicyclic compounds Chemical group 0.000 description 5
- 150000001338 aliphatic hydrocarbons Chemical group 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 229930186217 Glycolipid Natural products 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 210000004408 hybridoma Anatomy 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 2
- RKAWXNGUVJWTHV-UHFFFAOYSA-N 2-(4-amino-n-methylanilino)ethanesulfonic acid Chemical compound OS(=O)(=O)CCN(C)C1=CC=C(N)C=C1 RKAWXNGUVJWTHV-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 102000004856 Lectins Human genes 0.000 description 2
- 108090001090 Lectins Proteins 0.000 description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 125000004421 aryl sulphonamide group Chemical group 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000002523 lectin Substances 0.000 description 2
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical group CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 125000006574 non-aromatic ring group Chemical group 0.000 description 2
- 125000000962 organic group Chemical group 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000001422 pyrrolinyl group Chemical group 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 2
- 125000000335 thiazolyl group Chemical group 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- UTBXIKGTARXRTH-UHFFFAOYSA-N 1-hydroxy-2,3-dihydropyrrole Chemical group ON1CCC=C1 UTBXIKGTARXRTH-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- ZVDCCBZEETUVQC-UHFFFAOYSA-N 3-octadecylpyrrolidine-2,5-dione Chemical compound CCCCCCCCCCCCCCCCCCC1CC(=O)NC1=O ZVDCCBZEETUVQC-UHFFFAOYSA-N 0.000 description 1
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 1
- LVSPDZAGCBEQAV-UHFFFAOYSA-N 4-chloronaphthalen-1-ol Chemical compound C1=CC=C2C(O)=CC=C(Cl)C2=C1 LVSPDZAGCBEQAV-UHFFFAOYSA-N 0.000 description 1
- ORPXKVFCUSJGIS-UHFFFAOYSA-N 4-dodecylbenzenesulfonamide Chemical compound CCCCCCCCCCCCC1=CC=C(S(N)(=O)=O)C=C1 ORPXKVFCUSJGIS-UHFFFAOYSA-N 0.000 description 1
- RIXNIZKEKXPLIT-UHFFFAOYSA-N 5-nitronaphthalen-1-ol Chemical compound C1=CC=C2C(O)=CC=CC2=C1[N+]([O-])=O RIXNIZKEKXPLIT-UHFFFAOYSA-N 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 206010073306 Exposure to radiation Diseases 0.000 description 1
- 241001076084 Matus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 101710132457 Protein A1 Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- 150000001639 boron compounds Chemical class 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000004966 cyanoalkyl group Chemical group 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 125000005462 imide group Chemical group 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- FWFGVMYFCODZRD-UHFFFAOYSA-N oxidanium;hydrogen sulfate Chemical compound O.OS(O)(=O)=O FWFGVMYFCODZRD-UHFFFAOYSA-N 0.000 description 1
- 150000004989 p-phenylenediamines Chemical class 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000008301 phosphite esters Chemical class 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical compound NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- BUUPQKDIAURBJP-UHFFFAOYSA-N sulfinic acid Chemical compound OS=O BUUPQKDIAURBJP-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000004305 thiazinyl group Chemical group S1NC(=CC=C1)* 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
本発明は特定成分の測定方法に関し、特にパーオキシダ
ーゼの酵素反応を用いる特定成分の測定方法に関する。The present invention relates to a method for measuring a specific component, and particularly to a method for measuring a specific component using a peroxidase enzyme reaction.
生体成分などの特定成分を検出する各種の分析法が開発
されて米でいるが、それらの方法の中量も精度の高い方
法として、該特定成分とこれに対して特異的に結合しう
る物質(以後特異結合物質と称する)、例えば抗原と抗
体、ある種の糖鎖とレクチン、ビオチンとアビノン、プ
ロティンAとIgG、ホルモンとレセプター、酵素と基
質等の間の特異的結合反応を用いる方法が知られている
。
−般的には何らかの標識(ラベル)を付した特異結合物
質(以後標識体と称する)を用い特定成分に応じて変化
した該標識のシグナルを検出することにより特定成分の
測定が行われる。
特に支持体に直接的にまたは間接的に担持させた特定成
分を標識体と゛反応させ、両者の複合体として標識体を
固定し、実質的に特定成分に応じた標識からのシグナル
を検出する方法が適宜用いられる。
例えば電気泳動した蛋白質生体成分(特定成分)をデル
からニトロセルローズ膜上に転写担持し、標識体たとえ
ば抗体標識体と反応させシグナルを検出する方法、TL
Cプレート上に711]11した脂質等の特定成分に標
識体を反応させシグナルを検出する方法、膜上でDNA
と該DNAに対する標識した相補的DNAとを反応させ
シグナルを検出する方法或は免疫ffi鳳化学染色法な
どである。
これらの方法により、特定成分の定量や特定成分の特異
結合物質との反応性だけでなく、特定成分もしくは特異
結合物質の性質、存在状態などに対する多大な情報をう
ろことができる0例えば電気泳動後膜上に展開、担持さ
れた蛋白質や核酸、またはTLC上に展開した脂質成分
等の生体の特定成分と該特定成分に対する標識体とを結
合させた複合体上にシグナルを検出する方法に於ては特
定成分のシグナルの位置、移動度から該特定成分の分子
量、等電点或は極性等の情報かえられる。
また免疫組織化学染色法に於ては、組織上の目的とする
特定成分の存在場所、状態等の情報かえられる。Various analytical methods have been developed to detect specific components such as biological components, and these methods are highly accurate even when measuring medium amounts. (hereinafter referred to as specific binding substances), such as antigens and antibodies, certain sugar chains and lectins, biotin and avinone, protein A and IgG, hormones and receptors, enzymes and substrates, etc. Are known. - Generally, a specific component is measured by using a specific binding substance (hereinafter referred to as a label) attached with some kind of label and detecting the signal of the label that changes depending on the specific component. In particular, a method in which a specific component supported directly or indirectly on a support is reacted with a label, the label is immobilized as a complex of both, and a signal from the label substantially corresponding to the specific component is detected. is used as appropriate. For example, a method in which an electrophoresed protein biological component (specific component) is transferred and supported on a nitrocellulose membrane and reacted with a label, such as an antibody label, to detect a signal, TL
A method of detecting a signal by reacting a label with a specific component such as a lipid placed on a C plate, and DNA
A method of detecting a signal by reacting the DNA with a labeled complementary DNA, or an immunoffi chemical staining method, etc. With these methods, it is possible to obtain a great deal of information not only on the quantification of specific components and the reactivity of specific components with specific binding substances, but also on the properties and state of existence of specific components or specific binding substances. In a method of detecting a signal on a complex in which a specific component of a living body, such as a protein or nucleic acid developed or supported on a membrane, or a lipid component developed on a TLC, is bound to a label for the specific component. Information such as the molecular weight, isoelectric point, or polarity of a specific component can be obtained from the position and mobility of the signal of the specific component. Furthermore, in the immunohistochemical staining method, information such as the location and state of specific components of interest on the tissue can be changed.
前記した、支持体上に直接または間接的に担持させた複
合結合体上に実質的に特定成分量に応じてシグナルを検
出する特定成分の測定では対象とする特定成分が微量で
あるため標識が高感度に検出されること、また特定成分
に対するより多くの情報をうるため標識の検出法が高い
分解能をもったものであることが必須である。
特異結合物質の標識としては、放射性同位元素、蛍光物
質、発光物質、酵素等が用いられている。
放射性同位元素は放射活性の減衰や廃棄、被曝或は膜管
に巨費を要する等の問題があり、更に支持体に担持させ
た標識体上にシグナルを検出する際には写真感光材料の
感光、現像など長い時間と煩雑な操作を要する欠点があ
る。
蛍光物質もしくは発光物質は特殊な装置、設備が必要で
ある。
一方、W!を素を用いた場合、操作も比較的簡単で生成
色素はたやすく可視化でき、定量も可能である。従来、
標識酵素としてパーオキシダーゼ、7ルカリ7オス7ア
ターゼ、β−がラクトシグーゼ等が用いられてきた。支
持体上に担持せしめた複合結合体上に酵素反応により色
素を生成、沈着させる方法において、標識酵素としてパ
ーオキシダーゼが主として用いられ、その際、基質とし
て、従来ノアミ/ベンツノン、0−ノアニジノン、4−
クロロ−1−す7トール等が使用されてきた。
ノアミノベンツノンや0−ノアニジノンは毒性が強くバ
ックグランドが出やすい欠点がある。4−クロロ−1−
す7トールは他に比べやや感度が高いが、より微量の特
定成分を測定するため、もしくは、特定成分に対するよ
り多くの情報を明確に得るには、感度は充分とは言えな
い。
従って本発明の目的は、簡易に且つ高感度、高分解能で
ありしかも迅速な特定成分の測定方法を提供することで
ある。In the above-mentioned measurement of a specific component, in which a signal is detected substantially depending on the amount of a specific component on a complex conjugate directly or indirectly supported on a support, the specific component of interest is in a trace amount, so it is difficult to use a label. It is essential that the label detection method has high resolution in order to be detected with high sensitivity and to obtain more information about a specific component. Radioactive isotopes, fluorescent substances, luminescent substances, enzymes, etc. are used as labels for specific binding substances. Radioactive isotopes have problems such as attenuation of radioactivity, disposal, exposure to radiation, and the high cost of membrane tubes.Furthermore, when detecting a signal on a label supported on a support, the exposure of the photographic light-sensitive material, It has the disadvantage that it requires a long time and complicated operations such as development. Fluorescent or luminescent substances require special equipment and equipment. On the other hand, W! When dyes are used, the procedure is relatively simple, and the resulting dyes can be easily visualized and quantified. Conventionally,
As labeling enzymes, peroxidase, 7-lucali-7-o-7-atase, β-lactosigase, etc. have been used. In the method of producing and depositing a dye by enzymatic reaction on a complex conjugate carried on a support, peroxidase is mainly used as a labeling enzyme, and in this case, as a substrate, conventional noami/bentunone, 0-noanidinone, 4 −
Chloro-1-su7toll and the like have been used. Noaminobentunone and 0-noanidinone have the drawback of being highly toxic and prone to background. 4-chloro-1-
Although S7 Toll is slightly more sensitive than others, it cannot be said to be sensitive enough to measure trace amounts of specific components or to clearly obtain more information about specific components. Therefore, an object of the present invention is to provide a method for measuring a specific component simply, with high sensitivity, high resolution, and quickly.
前記目的に沿って種々検討した結果、測定対象の特定成
分とパーオキシダーゼを標識として有する標識体とから
なる複合結合体を支持体上に担持せしめ、該複合結合体
上にパーオキシダーゼの酵素反応によって色素を形成、
沈着せしめる特定成分の測定方法に於て、該酵素反応の
基質として過酸化水素、芳香族第一級アミン化合物及び
フェノール化合物の三者を用いる測定方法によって問題
点が解消され、前記本発明の目的が達成される。
次に本発明の詳細な説明する。
本発明に於て特定成分は支持体に物理的吸着、化学的結
合等により直接的に担持されてもよく、1つ以上の特異
結合物質を介して間接的に担持されてもよい。又、特定
成分を支持体上に直接もくくは間接的に担持せしめた後
、前記Ha体を反応させ前記複合結合体を形成させても
よいし、或は複合結合体を形成せしめた後に該複合結合
体を支持体上に直接もしくは間接的に担持せしめてもよ
い。更にPX:f&体は該特定成分と複合結合体を形成
し、支持体に担持されるが、特定成分と標識体は直接結
合してもよく、1つ以上の他の特異結合物質を介して結
合してもよい。
また本発明に於て標識体はパーオキシダーゼと抗パーオ
キシグーゼ抗体とで特異結合物質を重複して標識したも
のであってもよい。
複合結合体中のパーオキシダーゼの酵素反応のパーオキ
シダーゼの基質としては、過酸化水素、芳香族第一級ア
ミン化合物及び7工ノール化合物を用いる。パーオキシ
ダーゼと過酸化水素の作用により芳香族第一級アミン化
合物は酸化され、次いでフェノール化合物とカップリン
グして鮮かな青色色素が生成、沈着する。
従来の過酸化水素及び4−りaa−1−六7トールを基
質として用いるアナリティ力ルバイオヶミ ス ト リ
− (^nalyLical Biochemis
try) 里、 142−147(1982)に記載の
方法と比べ本発明の方法は発色時間が短縮され、スポッ
トは鮮明で感度は10倍以上上昇した。また、その結果
、パーオキシグ−ゼ標識体の量を低減する事ができコス
ト的にも有利である。
本発明において、対象とする特定成分は、その特定成分
に特異的に結合する特異結合物質が得られる物質又は物
質群である。
たとえば蛋白質、核酸、ホルモン、脂質、複合糖質、糖
脂質、多糖類、酵素、ビタミン、抗原、抗体等が挙げら
れる。
また本発明に使用し得る特異結合物質は、特定成分又は
他の特異結合物質と特異的に結合できる物質であり、特
定成分に応じて適当に選ぶ事ができる。たとえば、蛋白
質、核酸、ホルモン、脂質、複合糖質、糖脂質、多糖類
、酵素、ビタミン、抗原、抗体、レクチン、プロティン
A1アビジン、ビオチン、レセプター、補#素、酵素の
基質、毒素、補体及びこれらの複合体等が挙げられる。
本発明に使用し得る支持体としては、セルロースアセテ
ート、ニトロセルロース等の膜、ポリアクリルアミド等
のデル状支持体、TLCプレート等のシリカゾル担体、
プレート状、ビーズ状のプラスチック、ガラス、金属、
JaJll等が挙げられる6また組繊化学染色において
は、mmそのものも支持体として使用できる。
本発明において使用し得る芳香族第一級アミン化合物と
しては、〇−又はp−7ミノフ工ノール系化合物及び〇
−又はp−フェニレンジアミン系化合物及びそれらの塩
が挙げられる。
好ましくはp−フェニレンジアミン系化合物であり下記
−般式(1)で示されるものである。
−般式〔(〕
式中、A及びBは水素原子またはアルキル基を表し、A
とBは窒素原子と共に複素環を形成してもよく、D 、
E 、G及びJは水素原子、ハロゲン原子、ヒドロキシ
基、アミ7基、アルコキシ基、アシルアミド基、アリー
ルスルホンアミド基、フルキルスルホンアミド基または
アルキル基を表わす。
A及びBで表されるアルキル基としては、炭素原子数1
乃至6のものが好主しく、特に1乃至4のものが好まし
い0例えばメチル基、エチル基、ブチル基を挙げること
ができる。これらのアルキル基は置換基を有していても
よく置換基としては、例えばウレイド基、テトラヒドロ
7リル基、カルボキシル基、メタンスルホンアミド基、
スルホ基、メトキシ基、エトキシ基、メトキシエトキシ
基、/トキシエトキシエトキシ基、メトキシテトラエト
キシ基が亭げられる。
D、G及びJとしては水素原子、アルコキシ基及びフル
キルスルホンアミド基、アリールスルホンアミド基が好
ましく、さらに好ましくは水素原子である。Eとしては
水素原子、アルキル基、アシルアミド基が好ましく、よ
り好ましくは炭素原子数1〜3のアルキル基特にメチル
基である。また、−般式(1)で示される化合物の塩と
してはp−トルエンスルホン酸、スルホン酸、スルフィ
ン酸、硫酸エステル、スルファミン酸、チオ硫酸S−エ
ステル、カルボン酸、リン酸エステル、アミドリン酸、
リン酸、亜リン酸エステル、有機ホウ素化合物、塩酸及
び硫酸等の有機酸又は無機酸の塩を挙げることができ、
特にp−)ルエンスルホン酸塩、塩酸塩及び硫酸塩が好
ましい。
以下に本発明に係る芳香族第1級アミン化合物の代表的
具体例を示すが、本発明はこれに限定されるものではな
い。
例示化合物
(1−1)N、N−ジエチル−3−メチル−4−フミノ
アニリン
(1−2)N、N−ジエチル−4−フミノフニリン(1
−3)N−カルバミドメチル−N−メチル−4−7ミノ
アニリン
(1−4)N−カルバミドメチル−N−テトラヒドロフ
ルフリル−3−メチル−4−7ミノアニリン(1−5)
N−エチル−N−カルボキシメチル−3−メチル−4−
7ミノアニリン
(1−6)N−カルバミドメチル−N−エチル−3−メ
チル−4−7ミノアニリン
(1−7)N−エチル−N−テトラヒドロフル7リルー
3−メチル−4−7ミノフエノール(1−8)3−7セ
チルアミノー4−アミツノメチルアニリン
(1−9)N−エチル−N−βメタンスルホンアミドエ
チル−4−7ミノアニリン
(1−10)N−エチル−N−β−7タンスルホンアミ
ドエチルー3−メチル−4−アミノアニリン(1−11
)N−メチル−N−βスルホエチル−p−フェニレンジ
アミン
(1−12)N−エチル−N−ヒドロキンエチル−3−
メチル−4−アミノアニリン
(1−13)N−エチル−N−(2−(2−メトキシエ
トキシ)エチル〕−3−メチルー4−アミ7アニリン
(1−14)N−エチル−N−12−C2−<2−メト
キシエトキシ)エトキシ〕エチル)−3−メチル−4−
7ミノアニリン
(1−15)N−エチル−N−(2−12−C2−C2
−(2−ノドキシエトキシエトキシ)エトキシ〕エトキ
シ〕エトキシ)エチル〕−3−メチルー4−アミ/アニ
リン
(1−16)N、N−ノエチル−3、メタンスルホンア
ミドエチル−4−7ミノアニリン。
−般式(11で示される化合物の塩は、−般的に水溶性
であり、水もしくは緩衝液中に容易に溶解する事ができ
る。
本発明において使用し得る71/−ル化合物は、芳香族
第一級アミン化合物の酸化体とカップリングして色素を
生成する化合物であり、該生成色素の水に対する溶解性
を滅するため、ベンゼン環上に適当な置換基を置換した
フェノール化合物である。
該フェノール化合物の中でも好ましいのは、ヒドロキシ
ル基の4位が置換されていない又は芳香族第一級アミン
化合物の酸化体とカップリング反応する際に離脱しうる
基(以下、離脱基と称する)もしくは原子(以下離脱原
子と称する)で置換されているフェノール化合物である
。
本発明において有利に用いられる7エ/−ル化合物は次
の一般式[[[]で示される。
一般式(II)
O1+
式中R3は一価の有機基又は原子を表し、2は水素原子
、離脱基又は離脱原子を表し、kは1乃至4の整数を表
す。
Zで表される離脱原子としては、ハロゲン原子例えば、
塩素原子、臭素原子が挙げられる。
Zで表される離脱基としては、例えば−0R2゜−0C
OR2,−0SO□R2、−SR2、−0CON)IR
、、−0SO□NllR2゜れる、ここにR2及びR1
は水素原子、脂肪族炭化水素残基、脂環式化合物残基、
アリール基又はヘテロ環残基を表す6
R,で表される原子としてはハロゲン原子例えば塩素原
子、臭素原子が挙げられる。
R,で表される一価の有機基としては、例えば脂肪挨炭
化水素残基、脂環式化合物残基、ヘテロ環残基、アリー
ル基、 −5CN、 −OR,、−0COR,、−0S
O□R,、−SR,。
R1
びR5は水素原子、脂肪族炭化水素残基、脂環式化合物
残基、アリール基又はヘテロ環残基を表す。
R,、R,、R)、R4及びR5で表される脂肪族炭化
水素残基としては飽和のもの不飽和のもののいずれでも
よく、また直鎖のもの、分岐のもののいずれでもよい。
そして好ましくはアルキル基(例えばメチル基、エチル
基、プロピル基、イソプロピル基、ブチル基、し−ブチ
ル基、イソブチル基、ドデシル基、オクタデシル基の各
基)、アルケニル基(例えばアリル基、オクテニル基等
の各基)である。
RzRz、RitR−及びR1で表される脂環式化合物
残基としては5乃至6貝のもの、例えばシクロペンチル
基、シクロヘキシル基が挙げられる。
R+、R2,R*+R+及びR5で表されるヘテロ環残
基としてはビリノニル基、ビラノニル基、ビリグツニル
基、キ7リル基、ピロリノル基、7ラリル基、チエニル
基、ピペリジル基、ピロリル基 ピロリニル基、テトラ
ゾリル基、チアゾニル基、イミダゾリル基、モルホリル
基、フリル基、オキサシリル基、チアゾリル基、ベンツ
イミダゾリル基、ベンツオキサシリル基、ベンツチアゾ
リル基等の各基が代表的である。
R,、R,、R,、R4及びR9で表されるアリール基
としてはフェニル基、ナフチル基が代表的である。
前述の2つのR3が結合して形成するベンゼン環に融合
する非芳香族環としては5乃至6貝のもの例えばシクロ
ペンタン環、シクロヘキサン環、シクロヘキセン環が挙
げられる。
前述の2つのR1、特に5位と6位のR2が結合して形
成するベンゼン環と融合する芳香族環としては、5乃至
6員のものたとえば、フェニル基、ビリノニル基、ピラ
ジニル基、ビリグツニル基、ピロリジル基、7ラリル基
、チエニル基、ピペリノル基、ピロリル基、ピロリニル
基、チアジニル基、イミダゾリル基、フリル基、オキサ
シリル基、チアゾリル基等、が挙げられる。
以上のR,、R2,R,、R,及びR1で表される脂肪
族炭化水素残基、脂環式化合物残基、アリール基、ヘテ
ロ環残基、並びに前述の2つのR1が結合して形成する
非芳香族環、芳香族環は置換基を有していてもよい。
かかる置換基としては、例えばハロゲン原子(例えば塩
素原子、フッ素原子)、ニトロ基、シアノ基、ヒドロキ
シ基、ケト基、カルボキシル基、スルホ基、アミ7基(
例えば、アミノ、アルキルアミノ、ジアルキルアミ/、
アニソ/、N−フルキルアニソ/)、アルキル基(例え
ば、メチル、プロピル、イソプロピル、し−ブチル、オ
クタデシル、シアノアルキル、ハロアルキル、アルアル
キル)、アルケニル基、アリール基(例えば、フェニル
、トリル、アセチルアミノ7ヱニル、4−ラウロイルア
ミノフェニル、エトキシフェニル)へテロ環残基、アル
コキシ基(例えば、エトキシ、7エ/キシ、メトキシ、
テトラデシルオキシ)、アリールオキシ基(例えば、フ
ェノキシ、2.4−ノーt−7ミル7エ/キシ、p−t
−ブチルフェノキン、4−n−ドデシルオキシ7ヱノキ
シ、4−ヒドロキン−3−t−ブチルフェノキシ、4−
ヒドロキシ−3−n−ブチルフェノキシ)、アリールチ
オ基、アミド基(例えば、アセトアミド、メタンスルホ
ンアミド、p−ドデシルベンゼンスルホンアミド)、カ
ルバモイル基(例えば、N−p−カルボキシナトキシフ
ェニルカルバモイル、N、N−)へキンル力ルパモイル
、N−ベンジルカルバモイル、N−エチルカルバモイル
、N−7トキシエチルカルバモイル)、スル77モイル
基(例えば、N、N−ノエチルスル7アモイル)、フル
キルスルホニル基、7リールスルホニルi(例えば、ベ
ンゼンスルホニル、クークロロベンゼンスルホニル)、
アシル基(例えば、アセチル、p−クロロベンゾイル、
ベンゾイル)、アシルオキシ基(例えば、アセチルオキ
シ、m−タロロペンゾイルオキシ)、アシルオキシカル
ボニル基及びアルコキシカルボニル基(例えば、N−メ
トキンエチルカルバモイルメトキシカルボニル、エトキ
シカルボニル、メトキシカルボニル、トリエトキシカル
ボニル)、アリールオキシカルボニル基(例えばフェノ
キシカルボニル、p−ニトロフェノキシカルボニル)、
了り一ルチオカルボニル基(例えば、フェニルチオカル
ボニル)、イミド基(例えば、サクシンイミド、オクタ
デシルサクシンイミド)が挙げられる。
以下に本発明の71/−ル化合物の代表的具体例を示す
が、本発明に泪いられる化合物はこれに限定されるもの
ではない。
例示化合物
(2−1) 2−ベンツルー4−クロロフェノール(
2−2) N−ベンゾイル−4,6−フクロロー5−
メチル−2−フミノフエノール
(2−3) 2−ベンゾイルアミノ−5−7セトアミ
ノー4−クロロ7エ7−ル
(2−4) 4−クロロ−1−す7トール(2−5
) 4−メトキシ−1−す7トール(2−6)
2.4−ジクロロ−1−す7トール(2−7) 1−
ヒドロキシ−4−プロモーN−エチル−2−す7トアミ
ド
(2−8) 1−ヒドロキシ−4−メトキシ−N−プ
ロピル−2−す7トアミ ド
(2−9) 2.6−ノプロモー1,5−ノヒドロキ
ンーナ7タレン
(2−10) 1−ヒドロキシ−5−フェニルスルホ
ンアミドナフトール
(2−11) 1−ヒドロキシ−2,4−ジクロロ−
5−二トローナフトール
支持体に担持された特定成分とパーオキシグーゼ標識体
との複合結合体上に色素を生成沈着せしめるには1発色
用基質試液中に支持体を浸漬させれば良い6発色用基質
試験液は、適当なpHの緩衝液中に過酸化水素、芳香族
第一級アミン化合物及び7エ/−ル化合物を溶解し、調
製される。フェノール化合物は、少量の親水性の有機溶
剤たとえばメタ/−ル、エタノール、DMF等に溶解し
て加えても良い。
芳香族第一級アミン化合物と7二ノ一ル化合物とのモル
比は1対100から100対1が適当であり、1討10
からの1ON1が好ましい。
酵素反応により支持体上に色素が充分生成沈着した後、
未反応物質を洗い流し、反応を停止する。
生成色素についての情報は、目視にて、もしくは技術的
に公知な方法たとえば分光度計を用いて読み取る事がで
きる。As a result of various studies in line with the above objectives, we supported a complex conjugate consisting of a specific component to be measured and a label having peroxidase as a label on a support, and applied an enzymatic reaction of peroxidase onto the complex conjugate. Forms pigment,
In a method for measuring a specific component deposited, the problems are solved by a method using hydrogen peroxide, an aromatic primary amine compound, and a phenol compound as substrates for the enzyme reaction, and the above-mentioned object of the present invention is achieved. is achieved. Next, the present invention will be explained in detail. In the present invention, the specific component may be directly supported on the support by physical adsorption, chemical bonding, etc., or indirectly supported via one or more specific binding substances. Further, after the specific component is directly or indirectly supported on the support, the Ha body may be reacted to form the composite conjugate, or the composite conjugate may be formed and then the specific component may be supported directly or indirectly on the support. The composite conjugate may be supported directly or indirectly on a support. Furthermore, the PX:f& body forms a complex binding body with the specific component and is supported on the support, but the specific component and the label may be bound directly or via one or more other specific binding substances. May be combined. Further, in the present invention, the labeled body may be one in which a specific binding substance is labeled with peroxidase and an anti-peroxygose antibody. Hydrogen peroxide, an aromatic primary amine compound, and a heptanoyl compound are used as peroxidase substrates for the enzymatic reaction of peroxidase in the complex conjugate. Aromatic primary amine compounds are oxidized by the action of peroxidase and hydrogen peroxide, and then coupled with phenolic compounds to produce and deposit a bright blue pigment. Analytical Biochemistry Using Conventional Hydrogen Peroxide and 4-Aa-1-67 Tol as Substrates
Compared to the method described in Try) Sato, 142-147 (1982), the method of the present invention shortened the color development time, produced clear spots, and increased sensitivity by more than 10 times. Furthermore, as a result, the amount of peroxygase label can be reduced, which is advantageous in terms of cost. In the present invention, the target specific component is a substance or a group of substances from which a specific binding substance that specifically binds to the specific component is obtained. Examples include proteins, nucleic acids, hormones, lipids, complex carbohydrates, glycolipids, polysaccharides, enzymes, vitamins, antigens, antibodies, and the like. Further, the specific binding substance that can be used in the present invention is a substance that can specifically bind to a specific component or another specific binding substance, and can be appropriately selected depending on the specific component. For example, proteins, nucleic acids, hormones, lipids, complex carbohydrates, glycolipids, polysaccharides, enzymes, vitamins, antigens, antibodies, lectins, protein A1 avidin, biotin, receptors, cofactors, enzyme substrates, toxins, and complements. and complexes thereof. Supports that can be used in the present invention include membranes such as cellulose acetate and nitrocellulose, delta supports such as polyacrylamide, silica sol carriers such as TLC plates,
Plate-shaped, bead-shaped plastic, glass, metal,
JaJll, etc. 6 In addition, mm itself can be used as a support in composite fiber chemical dyeing. Examples of the aromatic primary amine compound that can be used in the present invention include 0- or p-7 minophenol compounds, 0- or p-phenylenediamine compounds, and salts thereof. Preferred is a p-phenylenediamine compound represented by the following general formula (1). -General formula [(] In the formula, A and B represent a hydrogen atom or an alkyl group, and A
and B may form a heterocycle together with the nitrogen atom, D,
E, G and J represent a hydrogen atom, a halogen atom, a hydroxyl group, an amide group, an alkoxy group, an acylamido group, an arylsulfonamide group, a furkylsulfonamide group or an alkyl group. The alkyl group represented by A and B has 1 carbon atom
The number of groups is preferably 6 to 6, and 1 to 4 is particularly preferable. Examples include methyl, ethyl, and butyl groups. These alkyl groups may have a substituent, and examples of the substituent include a ureido group, a tetrahydro-7lyl group, a carboxyl group, a methanesulfonamide group,
Examples include sulfo group, methoxy group, ethoxy group, methoxyethoxy group, /toxyethoxyethoxy group, and methoxytetraethoxy group. D, G and J are preferably a hydrogen atom, an alkoxy group, a furkylsulfonamide group, or an arylsulfonamide group, and more preferably a hydrogen atom. E is preferably a hydrogen atom, an alkyl group or an acylamido group, more preferably an alkyl group having 1 to 3 carbon atoms, especially a methyl group. - Salts of the compound represented by the general formula (1) include p-toluenesulfonic acid, sulfonic acid, sulfinic acid, sulfuric acid ester, sulfamic acid, thiosulfuric acid S-ester, carboxylic acid, phosphoric acid ester, amidophosphoric acid,
Mention may be made of salts of organic or inorganic acids such as phosphoric acid, phosphite esters, organic boron compounds, hydrochloric acid and sulfuric acid,
Particularly preferred are p-)luenesulfonate, hydrochloride and sulfate. Typical specific examples of the aromatic primary amine compound according to the present invention are shown below, but the present invention is not limited thereto. Exemplary compound (1-1) N,N-diethyl-3-methyl-4-fuminoaniline (1-2) N,N-diethyl-4-fuminoaniline (1
-3) N-carbamidomethyl-N-methyl-4-7minoaniline (1-4) N-carbamidomethyl-N-tetrahydrofurfuryl-3-methyl-4-7minoaniline (1-5)
N-ethyl-N-carboxymethyl-3-methyl-4-
7 Minoaniline (1-6) N-carbamidomethyl-N-ethyl-3-methyl-4-7 Minoaniline (1-7) N-ethyl-N-tetrahydrofur 7ly-3-methyl-4-7 Minophenol (1 -8) 3-7cetylamino-4-aminomethylaniline (1-9)N-ethyl-N-β-methanesulfonamidoethyl-4-7minoaniline (1-10)N-ethyl-N-β-7thanesulfone Amidoethyl-3-methyl-4-aminoaniline (1-11
) N-methyl-N-βsulfoethyl-p-phenylenediamine (1-12) N-ethyl-N-hydroquinethyl-3-
Methyl-4-aminoaniline (1-13)N-ethyl-N-(2-(2-methoxyethoxy)ethyl)-3-methyl-4-ami7aniline (1-14)N-ethyl-N-12- C2-<2-methoxyethoxy)ethoxy]ethyl)-3-methyl-4-
7minoaniline (1-15)N-ethyl-N-(2-12-C2-C2
-(2-nodoxyethoxyethoxy)ethoxy]ethoxy]ethoxy)ethyl]-3-methyl-4-ami/aniline (1-16)N,N-noethyl-3,methanesulfonamidoethyl-4-7minoaniline. - The salt of the compound represented by the general formula (11) is generally water-soluble and can be easily dissolved in water or a buffer solution. It is a compound that produces a dye by coupling with an oxidized product of a group primary amine compound, and is a phenol compound substituted with an appropriate substituent on the benzene ring in order to eliminate the solubility of the produced dye in water. Among the phenol compounds, preferred are groups that are unsubstituted at the 4-position of the hydroxyl group or groups that can leave during the coupling reaction with the oxidized product of the aromatic primary amine compound (hereinafter referred to as leaving groups); It is a phenol compound substituted with an atom (hereinafter referred to as a leaving atom). The 7-er/-el compound advantageously used in the present invention is represented by the following general formula [[[].General formula (II) O1+ In the formula, R3 represents a monovalent organic group or atom, 2 represents a hydrogen atom, a leaving group, or a leaving atom, and k represents an integer of 1 to 4. The leaving atom represented by Z includes a halogen atom, for example. ,
Examples include chlorine atom and bromine atom. The leaving group represented by Z is, for example, -0R2゜-0C
OR2, -0SO□R2, -SR2, -0CON)IR
,, -0SO□NllR2゜, where R2 and R1
is a hydrogen atom, an aliphatic hydrocarbon residue, an alicyclic compound residue,
The atom represented by 6R, which represents an aryl group or a heterocyclic residue, includes a halogen atom, such as a chlorine atom and a bromine atom. Examples of the monovalent organic group represented by R include aliphatic hydrocarbon residues, alicyclic compound residues, heterocyclic residues, aryl groups, -5CN, -OR,, -0COR,, -0S
O□R,, -SR,. R1 and R5 represent a hydrogen atom, an aliphatic hydrocarbon residue, an alicyclic compound residue, an aryl group, or a heterocyclic residue. The aliphatic hydrocarbon residues represented by R, R, R), R4 and R5 may be either saturated or unsaturated, and may be linear or branched. Preferably, an alkyl group (e.g., methyl group, ethyl group, propyl group, isopropyl group, butyl group, butyl group, isobutyl group, dodecyl group, octadecyl group), alkenyl group (e.g., allyl group, octenyl group, etc.) each group). Examples of the alicyclic compound residues represented by RzRz, RitR- and R1 include five to six groups, such as a cyclopentyl group and a cyclohexyl group. The heterocyclic residues represented by R+, R2, R*+R+ and R5 include bilinonyl group, bilanonyl group, biligtunyl group, x7lyl group, pyrrolinol group, 7ralyl group, thienyl group, piperidyl group, pyrrolyl group, pyrrolinyl group , a tetrazolyl group, a thiazonyl group, an imidazolyl group, a morpholyl group, a furyl group, an oxasilyl group, a thiazolyl group, a benzimidazolyl group, a benzoxasilyl group, a benzthiazolyl group, and the like. Typical aryl groups represented by R, R, R, R4 and R9 are phenyl and naphthyl groups. Examples of the non-aromatic ring fused to the benzene ring formed by the above-mentioned two R3s include those having five to six shells, such as a cyclopentane ring, a cyclohexane ring, and a cyclohexene ring. The aromatic ring fused with the benzene ring formed by bonding the above two R1s, particularly R2 at the 5th and 6th positions, includes 5- to 6-membered rings such as phenyl group, bilinonyl group, pyrazinyl group, and biligtunyl group. , pyrrolidyl group, 7ralyl group, thienyl group, piperinol group, pyrrolyl group, pyrrolinyl group, thiazinyl group, imidazolyl group, furyl group, oxacylyl group, thiazolyl group, and the like. The aliphatic hydrocarbon residues, alicyclic compound residues, aryl groups, heterocyclic residues represented by R, R2, R, R, and R1 above, and the two R1s described above are bonded together. The non-aromatic ring and aromatic ring formed may have a substituent. Examples of such substituents include halogen atoms (e.g. chlorine atoms, fluorine atoms), nitro groups, cyano groups, hydroxy groups, keto groups, carboxyl groups, sulfo groups, amine groups (
For example, amino, alkylamino, dialkylami/,
aniso/, N-furkyaniso/), alkyl groups (e.g. methyl, propyl, isopropyl, butyl, octadecyl, cyanoalkyl, haloalkyl, aralkyl), alkenyl groups, aryl groups (e.g. phenyl, tolyl, acetylamino7), enyl, 4-lauroylaminophenyl, ethoxyphenyl) heterocyclic residues, alkoxy groups (e.g. ethoxy, 7e/xy, methoxy,
(tetradecyloxy), aryloxy groups (e.g., phenoxy, 2,4-not-7 mil7e/oxy, p-t
-butylphenoquine, 4-n-dodecyloxy-7enoxy, 4-hydroquine-3-t-butylphenoxy, 4-
hydroxy-3-n-butylphenoxy), arylthio group, amide group (e.g. acetamide, methanesulfonamide, p-dodecylbenzenesulfonamide), carbamoyl group (e.g. N-p-carboxynatoxyphenylcarbamoyl, N,N -) Hequinyl lupamoyl, N-benzylcarbamoyl, N-ethylcarbamoyl, N-7toxyethylcarbamoyl), sulf77moyl group (e.g. N,N-noethylsulfamoyl), furkylsulfonyl group, 7lylsulfonyl i (e.g. benzenesulfonyl, cuchlorobenzenesulfonyl),
Acyl groups (e.g. acetyl, p-chlorobenzoyl,
benzoyl), acyloxy groups (e.g. acetyloxy, m-talolopenzoyloxy), acyloxycarbonyl groups and alkoxycarbonyl groups (e.g. N-methquinethylcarbamoylmethoxycarbonyl, ethoxycarbonyl, methoxycarbonyl, triethoxycarbonyl), aryl oxycarbonyl group (e.g. phenoxycarbonyl, p-nitrophenoxycarbonyl),
Examples include a ruthiocarbonyl group (eg, phenylthiocarbonyl) and an imide group (eg, succinimide, octadecylsuccinimide). Typical specific examples of the 71/- compound of the present invention are shown below, but the compounds applicable to the present invention are not limited thereto. Exemplary compound (2-1) 2-Benzu-4-chlorophenol (
2-2) N-benzoyl-4,6-fuchloro-5-
Methyl-2-fuminophenol (2-3) 2-benzoylamino-5-7cetamin-4-chloro7-ethyl (2-4) 4-chloro-1-su7tol (2-5
) 4-Methoxy-1-7toll (2-6)
2.4-dichloro-1-su7toll (2-7) 1-
Hydroxy-4-promo N-ethyl-2-su7tamide (2-8) 1-Hydroxy-4-methoxy-N-propyl-2-su7tamide (2-9) 2.6-nopromo1,5 -Nohydroquina 7talene (2-10) 1-Hydroxy-5-phenylsulfonamide naphthol (2-11) 1-Hydroxy-2,4-dichloro-
To generate and deposit a dye on a complex of a specific component and a peroxyguse label supported on a 5-nitronaphthol support, 1. Substrate for color development. 6. Substrate for color development. 6. Substrate for color development. 6. Substrate for color development. A test solution is prepared by dissolving hydrogen peroxide, an aromatic primary amine compound, and a 7-el compound in a buffer solution of an appropriate pH. The phenol compound may be added after being dissolved in a small amount of a hydrophilic organic solvent such as methanol, ethanol, DMF, or the like. The appropriate molar ratio of the aromatic primary amine compound to the 7-dinoyl compound is 1:100 to 100:1;
1ON1 from is preferred. After the dye is sufficiently generated and deposited on the support by the enzymatic reaction,
Wash away unreacted substances and stop the reaction. Information about the pigment formed can be read visually or using methods known in the art, such as spectrophotometry.
以下、本発明を実施例により具体的に説明するが、本発
明はその実施例によりその範囲を限定されるものではな
い。
実施例に
ニトロセルロース膜上での抗原の測定:純水にて洗浄後
、風乾したニトロセルロース膜(バイオラッド社製;厚
み0.45μ屑)に、リン酸緩衝液(以下PBSと称す
)にて段階希釈したヤギIgGの1μlをス叡7トした
。
風乾後1%牛血清アルブミン(BAS)−PBS溶液に
より4℃にて一晩ブロッキングを行い、次いでバーオキ
シグーゼ楳識つサぞ抗ヤギIgG抗体(カッペル社製:
1%OS八−PへlS溶液により1500倍希釈したも
の)と4°C2時間反応させた。0.05%Tu+ee
n 20(ポリオキシエチレンソルビタンモ/ラウレー
) ;和光純薬社製)−PBS溶液にて5回洗浄し発色
用基質試液中に浸漬した。 発色用基質試液は次の3種
を用い、比較した。。
(1) : 3mgの1−4−クロロ−1−す7トー
ルを1zlのメタノールに溶解し、5zlの0.05M
)リス塩酸緩衝液(pH7,4,200xHNaC1
含有;以下TBSと称す)を加えるさらに3%過酸化水
素20μlを加える。
(2)=(1)の試液にN−エチル−N−β−メタンス
ルホンアミドエチル−3−メチル−4−アミ/アニリン
3/2硫酸1水塩11gを加えた。
(3):(1)の試液にN、N−ジエチル−3−メチル
−4−7ミノアニリン塩酸塩1簾2を加えた。
15分間反応後、充分水洗し、風乾した。発色用基質試
液(1)を用いた場合、スポットは灰紫色であり1、
Oz gのヤギIgG Lか検出できなかったが発色用
基質試液(2)及び(3)を用いた場合スポットは鮮や
かな青色で1agのヤギIgGが検出可能であった。
′実施例(2)
: TLCプレート上での糖脂質抗原の測定:TLCプ
レート(ポリグラム、マチエリ−・ナーデル社製)上に
牛脳より分離精製したGM、が〃ングリオシドな量を変
化させクロロホルム、メタノール混合液に溶解しスポッ
トした後、クロロホルム対メタノール対0.5%塩化カ
ルシウム水溶液(55対45対10 V/V)の展開液
にて展開した。風乾後1%ポリビニルピロリドン、1%
オパルプミンーPBS溶液にて4℃、−晩ブロッキング
し、ウサギにて作製した。抗GMいガングリオシド抗血
清(1%ポリビニルピロリドン、1%オパルプミンーP
BS溶液にて500倍希釈)と37°C2時間反応させ
た。
0.05%Tween−20−PBS溶液にて3面洗浄
後パーオキシグーゼ標識ヤギ抗マウスイムノグロブリン
抗体(カッベル社!:3%ポリビニルピロリドン−PB
S溶液にて1500倍希釈)と37℃、2時間反応させ
た。
0.05%Tween −20−PBSS液にて3回洗
浄後発色用基質試液中に浸漬した0発色用基質試液は次
の3種を用い、比較した。
(1):実施例1の(1)と同様
(2) : (1)にN−エチル−N−ヒドロキシルエ
チル−3−メチル−4−7ミノアニリン硫fil水塩f
gを加えた。
(3) : (2)の試液中、4−クロロ−1−ナフト
ールの代わりに4−メトキシ−1−す7トールを用いた
。
15分間反応後充分水洗し、風乾した。
(1)の発色用基質試液を用いた場合、スポットは灰紫
色であり、4HのCM、yングリオシドしが検出できな
かったが、(2)及び(3)の試液を用いた場合、スポ
−/ )は鮮かな青色で0,2xgまで検出可能であっ
た。
実施例3
:抗体及びハイプリドーマのスクリーニング:αビアフ
チトリプシン50μ
全アジュバントと共にBajjb/Cマウス(雌、6週
齢)の腹腔内に注射した。3週間後、さらにαピアンチ
トリプシン50μgを70インドの不完全7ジユバンド
と共に腹腔内に注射し、さらに2週間後α1ーアンチト
リブFン30μgをPBSに溶解し、静脈注射した。
最゛終免疫の3日後#臓細胞を取り出し、常法に従い、
マツスミエローマ細胞X 63.6.5.3と融合した
。96穴プレ一ト5枚に分配しHAT選択培地にて培養
した。
融合の3週間後ハイプリドーマのコロニーが生成したウ
ェルについて、抗体の測定を以下の方法にて行った。
ニトロセルロースを4λl角の正方形に切断し、おのお
のにαビアフチトリプシン500μy/zIPBS溶液
1μiをスポットした.96穴マイクロタイタープレー
)1六当r)1枚ずつ加え、1%IIIAs−P[lS
溶液にで4℃、1晩ブロツキングした。PBSにて洗浄
後、ハイプリドーマの培養上ff140μlを加え、室
温にで2時間反応させた.0.05%Tweenー20
ーP[lS溶液にで3回洗浄した後、バーオキシグーゼ
標識ヤギ抗マウスイムノグロブリン抗体(カフベル社製
;1%BAS−PBS溶液にて1500倍希釈したちの
)を40μ!加え、室温にて2時間反応させた, 0.
05%T*eeIIー20ーPBS溶液にて3回洗浄後
、発色用基質試液を加え、ニトロセルロース上に色素が
生成したものを抗体活性陽性としr二0発色泪基質試液
として
(1):実施例1の(1)と同様
(2) : (1)にN,N〜ノエチル−4−アミノア
ニリン硫酸塩1りを加えた、の2種票を用い比較した。EXAMPLES Hereinafter, the present invention will be specifically explained using Examples, but the scope of the present invention is not limited by the Examples. Measurement of antigen on nitrocellulose membrane in Example: After washing with pure water, air-dried nitrocellulose membrane (manufactured by Bio-Rad; thickness 0.45 μm scraps) was coated with phosphate buffer (hereinafter referred to as PBS). 1 μl of serially diluted goat IgG was added to the tube. After air-drying, blocking was performed overnight at 4°C with a 1% bovine serum albumin (BAS)-PBS solution, and then anti-goat IgG antibody (manufactured by Kappel:
The mixture was reacted with 1% OS8-P diluted 1500 times with an IS solution at 4°C for 2 hours. 0.05%Tu+ee
n20 (polyoxyethylene sorbitan mo/Laurey) (manufactured by Wako Pure Chemical Industries, Ltd.) - washed five times with a PBS solution and immersed in a coloring substrate reagent solution. The following three types of coloring substrate test solutions were used and compared. . (1): Dissolve 3 mg of 1-4-chloro-1-su7tol in 1 zl of methanol, and add 5 zl of 0.05M
) Lis-HCl buffer (pH 7, 4, 200xHNaCl
(hereinafter referred to as TBS) and further add 20 μl of 3% hydrogen peroxide. (2)=11 g of N-ethyl-N-β-methanesulfonamidoethyl-3-methyl-4-ami/aniline 3/2 sulfuric acid monohydrate was added to the test solution of (1). (3): To the test solution of (1), 1 and 2 parts of N,N-diethyl-3-methyl-4-7minoaniline hydrochloride was added. After reacting for 15 minutes, it was thoroughly washed with water and air-dried. When using the coloring substrate test solution (1), the spot is grayish-purple;
Oz g of goat IgG L could not be detected, but when coloring substrate test solutions (2) and (3) were used, the spot was bright blue and 1 ag of goat IgG could be detected.
'Example (2): Measurement of glycolipid antigen on a TLC plate: GM isolated and purified from bovine brain on a TLC plate (Polygram, manufactured by Mattieri-Nardel) was mixed with chloroform, chloroform, and glioside in different amounts. After dissolving in a methanol mixture and spotting, it was developed with a developing solution of chloroform, methanol, and 0.5% calcium chloride aqueous solution (55:45:10 V/V). 1% polyvinylpyrrolidone after air drying, 1%
Blocking was performed at 4° C. overnight with an opalpmin-PBS solution, and the cells were prepared in rabbits. Anti-GM ganglioside antiserum (1% polyvinylpyrrolidone, 1% opalpmin-P
500 times diluted with BS solution) at 37°C for 2 hours. After washing 3 sides with 0.05% Tween-20-PBS solution, peroxyguse-labeled goat anti-mouse immunoglobulin antibody (Cubbell Co., Ltd.: 3% polyvinylpyrrolidone-PB)
(diluted 1,500 times with S solution) at 37°C for 2 hours. The following three types of substrate reagents for color development, which were washed three times with 0.05% Tween-20-PBSS and then immersed in the substrate reagent solution for color development, were compared. (1): Same as (1) of Example 1 (2): In (1), N-ethyl-N-hydroxylethyl-3-methyl-4-7 minoaniline sulfur filtrate f
g was added. (3): In the test solution of (2), 4-methoxy-1-su7thol was used instead of 4-chloro-1-naphthol. After reacting for 15 minutes, it was thoroughly washed with water and air-dried. When the coloring substrate reagent solution (1) was used, the spot was grayish-purple and 4H CM and y glioside could not be detected, but when the reagent solutions (2) and (3) were used, the spot was gray-purple. /) was bright blue and detectable up to 0.2xg. Example 3: Screening for antibodies and hybridomas: α-biaftitrypsin 50μ was injected intraperitoneally with total adjuvant into Bajjb/C mice (female, 6 weeks old). Three weeks later, 50 μg of α-pianantitrypsin was injected intraperitoneally together with a 70-diamond incomplete 7-day band, and after another 2 weeks, 30 μg of α1-antitrib F was dissolved in PBS and intravenously injected. 3 days after the final immunization # Take out the visceral cells and follow the standard method.
It was fused with Matus myeloma cell X 63.6.5.3. The cells were divided into five 96-well plates and cultured in HAT selection medium. Three weeks after the fusion, antibodies were measured in the wells in which hybridoma colonies had formed using the following method. Nitrocellulose was cut into 4λl squares, and 1μi of α-biaphtitrypsin 500μy/zIPBS solution was spotted on each square. 96-hole microtiter plate) 16 wells) Add 1 plate at a time, add 1% IIIAs-P
The solution was blocked overnight at 4°C. After washing with PBS, 140 μl of ff was added to the hybridoma culture and allowed to react at room temperature for 2 hours. 0.05% Tween-20
After washing three times with -P[lS solution, 40 μl of Baroxyguse-labeled goat anti-mouse immunoglobulin antibody (manufactured by Cafbel; diluted 1500 times with 1% BAS-PBS solution) was added to the solution. and allowed to react at room temperature for 2 hours.
After washing three times with 05% T*eeII-20-PBS solution, a coloring substrate reagent solution is added, and if a dye is formed on the nitrocellulose, it is considered positive for antibody activity and is used as a r20 coloring substrate reagent solution (1): Same as (1) of Example 1 (2): Comparison was made using two types of charts: (1) with one portion of N,N to noethyl-4-aminoaniline sulfate added.
Claims (3)
として有している標識体とから成る複合結合体を支持体
上に担持せしめ、該複合結合体上にパーオキシダーゼの
酵素反応によって色素を形成、沈着せしめる特定成分の
測定方法において、該酵素反応の基質として過酸化水素
、芳香族第一級アミン化合物及びフエノール化合物の三
者を用いることを特徴とする特定成分の測定方法。(1) A complex conjugate consisting of a specific component to be measured and a label having peroxidase as a label is supported on a support, and a dye is formed on the complex conjugate by an enzymatic reaction of peroxidase. . A method for measuring a specific component deposited, the method comprising using hydrogen peroxide, an aromatic primary amine compound, and a phenol compound as substrates for the enzyme reaction.
担持せしめた後、前記標識体を反応させ、複合結合体を
形成せしめることを特徴とする特許請求の範囲第1項記
載の特定成分の測定方法。(2) The specific component according to claim 1, wherein the specific component is directly or indirectly supported on a support, and then the label is reacted to form a complex conjugate. How to measure.
体を支持体上に直接もしくは間接的に担持せしめること
を特徴とする特許請求の範囲第1項記載の特定成分の測
定方法。(3) The method for measuring a specific component according to claim 1, characterized in that, after forming the composite conjugate, the composite conjugate is directly or indirectly supported on a support.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61150723A JP2546991B2 (en) | 1986-06-26 | 1986-06-26 | Method for measuring specific component using peroxidase enzymatic reaction |
US07/066,186 US4921791A (en) | 1986-06-26 | 1987-06-25 | Method for measuring specific component using peroxidase enzyme reaction |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61150723A JP2546991B2 (en) | 1986-06-26 | 1986-06-26 | Method for measuring specific component using peroxidase enzymatic reaction |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS636462A true JPS636462A (en) | 1988-01-12 |
JP2546991B2 JP2546991B2 (en) | 1996-10-23 |
Family
ID=15503000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61150723A Expired - Lifetime JP2546991B2 (en) | 1986-06-26 | 1986-06-26 | Method for measuring specific component using peroxidase enzymatic reaction |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2546991B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013508691A (en) * | 2009-10-20 | 2013-03-07 | ダコ・デンマーク・エー/エス | Immunochemical detection of single target entities |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5645198A (en) * | 1979-09-20 | 1981-04-24 | Wako Pure Chem Ind Ltd | Determination of amount of hydrogen peroxide of activity of peroxidase |
JPS57110197A (en) * | 1980-12-29 | 1982-07-08 | Fuji Photo Film Co Ltd | Determination of hydrogen peroxide |
JPS5990054A (en) * | 1982-11-15 | 1984-05-24 | Takeda Chem Ind Ltd | Method and reagent for immunochemical mesurement of human chorionic gonadotropin |
-
1986
- 1986-06-26 JP JP61150723A patent/JP2546991B2/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5645198A (en) * | 1979-09-20 | 1981-04-24 | Wako Pure Chem Ind Ltd | Determination of amount of hydrogen peroxide of activity of peroxidase |
JPS57110197A (en) * | 1980-12-29 | 1982-07-08 | Fuji Photo Film Co Ltd | Determination of hydrogen peroxide |
JPS5990054A (en) * | 1982-11-15 | 1984-05-24 | Takeda Chem Ind Ltd | Method and reagent for immunochemical mesurement of human chorionic gonadotropin |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013508691A (en) * | 2009-10-20 | 2013-03-07 | ダコ・デンマーク・エー/エス | Immunochemical detection of single target entities |
Also Published As
Publication number | Publication date |
---|---|
JP2546991B2 (en) | 1996-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1341637C (en) | Chemiluminescent acridinium salts | |
EP0579676B1 (en) | Method for specific binding assays using a releasable ligand | |
DE69022255T2 (en) | Beta-lactamase tests using chromogenic precipitating substrates. | |
JP2002207039A (en) | Immunoassay for hiv protease inhibitor | |
JP3190730B2 (en) | Immunoassay using a novel labeled drug hapten analog | |
JP2948904B2 (en) | Catalyzed reporter deposition | |
JPS636462A (en) | Method for measuring specific component by using peroxidase enzyme reaction | |
EP0656422B1 (en) | Chloramphenicol acetyl transferase (CAT) assay | |
US4921791A (en) | Method for measuring specific component using peroxidase enzyme reaction | |
EP0576095B1 (en) | Immunoassays with labeled thyronine hapten analogues | |
US5427907A (en) | Assay for equine infectious anemia virus | |
JP3177964B2 (en) | Coloring method, enzyme immunoassay using the method, and immunochromatography | |
EP0682254A1 (en) | Enzyme linked chemiluminescent assay | |
JPS5886461A (en) | Reagent for immunity test, test kit and immunity test method using said reagent and kit | |
EP0584854B1 (en) | Immunoassay using carbamazepine analogues labelled with horseraddish peroxidase | |
US5578457A (en) | Immunoassays with novel labeled carbamazepine hapten analogues | |
JPS63209600A (en) | Measurement by peroxidase label | |
JPH0257200A (en) | Measurement of specific component using enzyme reaction of peroxidase | |
JPS6371654A (en) | Method for measuring specific component by using bioxidase enzyme reaction | |
JP2591089B2 (en) | Immunological detection reagents | |
JPH04232464A (en) | Amine rich protein | |
JPH0272899A (en) | Method for detecting a substance having a hydrolase activity and a bicyclic compound | |
JPH07260787A (en) | Peroxidase immunological staining method and stabilization of aromatic primary amine compound solution | |
JPH06324040A (en) | Immune dyeing method for peroxidases and stabilizing method for solution of aromatic primary amine compound | |
JPH02275360A (en) | Build-up of signal in magnetic immnoassay by depression of enzyme catalysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
EXPY | Cancellation because of completion of term |